On Monday, Immix Biopharma Inc (NASDAQ: IMMX) opened lower -6.09% from the last session, before settling in for the closing price of $3.61. Price fluctuations for IMMX have ranged from $1.34 to $3.66 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -43.61%. Company’s average yearly earnings per share was noted 5.59% at the time writing. With a float of $16.20 million, this company’s outstanding shares have now reached $28.41 million.
Immix Biopharma Inc (IMMX) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Immix Biopharma Inc is 43.82%, while institutional ownership is 8.28%. The most recent insider transaction that took place on Sep 17 ’25, was worth 5,050. In this transaction CEO and Chairman of this company bought 2,500 shares at a rate of $2.02, taking the stock ownership to the 1,140,937 shares. Before that another transaction happened on Sep 16 ’25, when Company’s CFO bought 2,600 for $1.97, making the entire transaction worth $5,122. This insider now owns 290,659 shares in total.
Immix Biopharma Inc (IMMX) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.24 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.16) by -0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.59% per share during the next fiscal year.
Immix Biopharma Inc (NASDAQ: IMMX) Trading Performance Indicators
Check out the current performance indicators for Immix Biopharma Inc (IMMX). In the past quarter, the stock posted a quick ratio of 1.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.76 in one year’s time.
Technical Analysis of Immix Biopharma Inc (IMMX)
Looking closely at Immix Biopharma Inc (NASDAQ: IMMX), its last 5-days average volume was 0.93 million, which is a jump from its year-to-date volume of 0.22 million. As of the previous 9 days, the stock’s Stochastic %D was 88.94%.
During the past 100 days, Immix Biopharma Inc’s (IMMX) raw stochastic average was set at 81.92%, which indicates a significant increase from 77.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.31 in the past 14 days, which was higher than the 0.20 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.36, while its 200-day Moving Average is $2.16. However, in the short run, Immix Biopharma Inc’s stock first resistance to watch stands at $3.65. Second resistance stands at $3.90. The third major resistance level sits at $4.10. If the price goes on to break the first support level at $3.20, it is likely to go to the next support level at $3.00. Should the price break the second support level, the third support level stands at $2.75.
Immix Biopharma Inc (NASDAQ: IMMX) Key Stats
There are currently 33,036K shares outstanding in the company with a market cap of 97.75 million. Presently, the company’s annual sales total 0 K according to its annual income of -21,610 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -6,620 K.
